www.uhasselt.be
DSpace

Document Server@UHasselt >
Research >
Research publications >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/9821

Title: High-dose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoL
Authors: Pijls-Johannesma, Madelon
Houben, Ruud
Boersma, Liesbeth
Grutters, Janneke
SEGHERS, Katarina
Lambin, Philippe
Wanders, Rinus
De Ruysscher, Dirk
Issue Date: 2009
Publisher: ELSEVIER IRELAND LTD
Citation: RADIOTHERAPY AND ONCOLOGY, 91(3). p. 443-448
Abstract: Background and purpose: Aggressive radiotherapy or concurrent chemo-radiation therapy for lung cancer leads to a high incidence of severe, mostly esophageal, toxicity. The purpose of this study was to investigate the evolution of quality of life (QoL) in patients with lung cancer, selected for curative radiotherapy (RT) or chemo-RT. Methods: Seventy-five lung cancer patients completed a longitudinal the EORTC QLQ-C30 and LC13. Linear mixed regression models were fitted to investigate the impact of different factors on overall QoL. Results: Overall QoL decreased shortly after the end of RT (4 points, p = 0.19), but increased back to baseline within 3 months. Mean scores of role functioning (p = 0.018), cognitive functioning (p = 0.002), dyspnoea (EORTC QLQ-LC13: p = 0.043), dysphagia (p 0,005) and hoarseness (p = 0.029), showed a significant worsening over time. Emotional functioning (p = 0.033) improved significantly over time. Severe esophagitis (>= grade 2) was reported in only 12% of the patients. Next to maximal esophageal toxicity >= grade 2 (p = 0.010), also tumor stage IIIA (p < 0.001), tumor stage IIIB (p = 0.003), gender (p = 0.042) and fatigue (p < 0.001) appeared to be significant predictors of QoL. Conclusion: High-dose radiotherapy or concurrent chemo-radiation in the treatment of lung cancer seems to be a well-tolerated treatment option with preservation of QoL. (C) 2009 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 91 (2009) 443-448
Notes: [Pijls-Johannesma, Madelon; Houben, Ruud; Boersma, Liesbeth; Grutters, Janneke; Lambin, Philippe; Wanders, Rinus; De Ruysscher, Dirk] MAASTRO Clin, Dept Radiat Oncol, NL-6202 AZ Maastricht, Netherlands. [Pijls-Johannesma, Madelon; Boersma, Liesbeth; Lambin, Philippe; Wanders, Rinus; De Ruysscher, Dirk] Univ Med Ctr Maastricht, GROW Res Inst, Maastricht, Netherlands. [Seghers, Katarina] Hasselt Univ, Ctr Stat, Diepenbeek, Belgium.
URI: http://hdl.handle.net/1942/9821
DOI: 10.1016/j.radonc.2009.02.010
ISI #: 000266749200026
ISSN: 0167-8140
Category: A1
Type: Journal Contribution
Validation: ecoom, 2010
Appears in Collections: Research publications

Files in This Item:

Description SizeFormat
Published version301.11 kBAdobe PDF

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.